Latest News and Press Releases
Want to stay updated on the latest news?
-
OTC:RTON will begin marketing the super premium products of HONEY® Brands throughout its growing network of retailers.
-
DALLAS, April 10, 2024 (GLOBE NEWSWIRE) -- Right on Brands, Inc. (OTC PINK: RTON) ("RTON" or the "Company"), a fully reporting SEC company and a leading developer of a diverse range of hemp-based...
-
InMed Launches THCV, Expanding its Portfolio of Rare Cannabinoids for the Health and Wellness Sector
Produces highly pure d9-dominant THCV, a non-intoxicating cannabinoidBolsters Company’s commercial portfolio, which also includes CBDV, CBC and CBTTHCV has been researched for a variety of potential...
-
AUSTIN, Texas, Dec. 08, 2021 (GLOBE NEWSWIRE) -- SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Right on Brands, Inc. (OTC PINK: RTON), a fully reporting SEC filer...
-
ATLANTA, Nov. 12, 2021 (GLOBE NEWSWIRE) -- The locally owned cannabis dispensary, ATLRx, now carries the rare cannabinoid known as Tetrahydrocannabivarin or THC-V. The hemp-derived minor cannabinoid...
-
ROXBORO, N.C., June 02, 2021 (GLOBE NEWSWIRE) -- Open Book Extracts (OBX), a Roxboro, NC-based leading ingredient manufacturer and product development house for the industry’s most innovative and...
-
JACKSONVILLE, Fla., April 27, 2021 (GLOBE NEWSWIRE) -- Acquired Sales Corp. (OTCQX: AQSP) (www.AcquiredSalesCorp.com), which plans to change its name to LFTD Inc., today announced that its...
-
ROXBORO, N.C., June 15, 2020 (GLOBE NEWSWIRE) -- Open Book Extracts, one of the leading vertically integrated, cGMP certified processors of high-quality cannabinoid products, is pleased to announce...
-
SAN FRANCISCO, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) -- LEVEL™, a cannabinoid company that facilitates custom cannabis experiences for patients and consumers, has announced a unique licensing...
-
CINCINNATI, OH, June 05, 2018 (GLOBE NEWSWIRE) -- Callitas (CSE:LILY) (OTCQB:MPHMF) (FWB:T3F2), (the “Company” or “Callitas”), an integrated clinical-stage pharmaceutical development and OTC...